(Q34025008)
Statements
1 reference
Gevokizumab, an anti-IL-1β mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis and cardiovascular disease (English)
1 reference
Janina Geiler
1 reference
1 December 2010
1 reference
1 reference
12
1 reference
755-769
1 reference
Identifiers
1 reference